🇺🇸 FDA
Patent

US 9527919

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

granted A61KA61K2039/505A61K39/39558

Quick answer

US patent 9527919 (High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection) held by The Regents of the University of California expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K2039/505, A61K39/39558, A61K51/1096, A61P